Spectral Medical (EDT) Competitors C$0.82 -0.01 (-1.20%) As of 08/1/2025 02:31 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock EDT vs. AKU, GEN, LMD, LXG, SQD, DXD, MBI, BUX, CRL, and NBLYShould you be buying Spectral Medical stock or one of its competitors? The main competitors of Spectral Medical include Akumin (AKU), GeneNews (GEN), LED Medical Diagnostics (LMD), LexaGene (LXG), SQI Diagnostics (SQD), 3D Signatures (DXD), Med Biogene (MBI), Biomark Diagnostics (BUX), Charles River Laboratories International (CRL), and Neighbourly Pharmacy (NBLY). These companies are all part of the "medical" sector. Spectral Medical vs. Its Competitors Akumin GeneNews LED Medical Diagnostics LexaGene SQI Diagnostics 3D Signatures Med Biogene Biomark Diagnostics Charles River Laboratories International Neighbourly Pharmacy Spectral Medical (TSE:EDT) and Akumin (TSE:AKU) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability, media sentiment and institutional ownership. Is EDT or AKU more profitable? Spectral Medical has a net margin of 0.00% compared to Akumin's net margin of -34.67%. Akumin's return on equity of -483.86% beat Spectral Medical's return on equity.Company Net Margins Return on Equity Return on Assets Spectral MedicalN/A -973.97% -93.22% Akumin -34.67%-483.86%0.47% Which has more volatility and risk, EDT or AKU? Spectral Medical has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500. Comparatively, Akumin has a beta of 0.15, meaning that its stock price is 85% less volatile than the S&P 500. Which has stronger earnings and valuation, EDT or AKU? Spectral Medical has higher earnings, but lower revenue than Akumin. Spectral Medical is trading at a lower price-to-earnings ratio than Akumin, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSpectral MedicalC$1.90M121.38-C$18.68M-C$0.07-11.71AkuminC$737.69M0.00-C$255.80M-C$3.80N/A Does the media refer more to EDT or AKU? In the previous week, Spectral Medical's average media sentiment score of 0.00 equaled Akumin'saverage media sentiment score. Company Overall Sentiment Spectral Medical Neutral Akumin Neutral Do institutionals & insiders have more ownership in EDT or AKU? 13.0% of Spectral Medical shares are held by institutional investors. Comparatively, 30.3% of Akumin shares are held by institutional investors. 18.2% of Spectral Medical shares are held by company insiders. Comparatively, 33.0% of Akumin shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryAkumin beats Spectral Medical on 6 of the 10 factors compared between the two stocks. Get Spectral Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for EDT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EDT vs. The Competition Export to ExcelMetricSpectral MedicalDiagnostics & Research IndustryMedical SectorTSE ExchangeMarket CapC$230.63MC$847.16MC$5.48BC$6.20BDividend Yield1.45%5.44%4.73%6.72%P/E Ratio-11.712.1828.6763.43Price / Sales121.38483.56373.901,251.00Price / Cash82.5011.4235.4583.29Price / Book-10.252.708.274.87Net Income-C$18.68MC$334.07BC$3.24BC$301.20M7 Day Performance-1.20%-1.46%-3.69%-2.26%1 Month Performance1.23%-2.14%4.33%0.81%1 Year Performance38.98%-7.51%25.95%26.63% Spectral Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EDTSpectral MedicalN/AC$0.82-1.2%N/A+41.4%C$230.63MC$1.90M-11.7129News CoverageAKUAkuminN/AN/AN/AN/AC$37.20MC$737.69M-0.141,527GENGeneNewsN/AN/AN/AN/AC$25.49MC$234.59K-2.212,700LMDLED Medical DiagnosticsN/AC$0.40+∞N/A+0.0%C$15.51MC$14.96M-10.2646Gap UpLXGLexaGeneN/AC$0.11-19.2%N/A+0.0%C$14.77MC$110.93K-1.3141High Trading VolumeSQDSQI DiagnosticsN/AC$0.02flatN/A+0.0%C$6.11MC$3.04M-0.30147,000Gap UpDXD3D SignaturesN/AC$0.04+∞N/A+0.0%C$2.66MN/A-0.91N/AGap UpMBIMed BiogeneN/AC$0.05-18.2%N/A+0.0%C$597KN/A-7.5080Gap DownBUXBiomark DiagnosticsN/AN/AN/AN/A$0.00N/A0.00N/ANews CoveragePositive NewsGap DownHigh Trading VolumeCRLCharles River Laboratories InternationalN/AN/AN/AN/A$0.00N/A0.0021,400News CoverageGap DownNBLYNeighbourly PharmacyN/AN/AN/AN/AC$835.51MC$874.61M-25.483,648High Trading Volume Related Companies and Tools Related Companies Akumin Competitors GeneNews Competitors LED Medical Diagnostics Competitors LexaGene Competitors SQI Diagnostics Competitors 3D Signatures Competitors Med Biogene Competitors Biomark Diagnostics Competitors Charles River Laboratories International Competitors Neighbourly Pharmacy Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:EDT) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectral Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectral Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.